The stock currently offers a 4% dividend yield ... We can see from my table above that Sanofi is undervalued by 55% to peers ...

Further boosting the pipeline, mid-stage drugs like Sanofi/Regeneron’s itepekimab ... 23 abstracts at the American Society of ...

Vandana Singh Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff Sanofi plans to spin off its consumer healthcare division, which could be valued at over $16.8 ...

Sanofi (NASDAQ:SNY – Free Report) by 30.4% during the third quarter, according to the company in its most recent filing with ...

Novavax's (NVAX) stock was trading down more than 6% Tuesday afternoon after ... and trying to market this," CEO John Jacobs ...

Shares of NASDAQ SNY opened at $50.14 on Wednesday. The stock has a market cap of $127.25 billion, a PE ratio of 25.83, a ...

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Additionally, Sanofi plans a share buyback ... Jefferies also assigned a Buy rating to the stock with a €120.00 price target. TipRanks tracks over 100,000 company insiders, identifying the ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...